Evotec SE (EVO) Other Operating Expenses (2009 - 2025)
Evotec SE's (EVO) quarterly Other Operating Expenses came in at $63.0 million in Q4 2025, down 1.01% year-over-year from $63.7 million in Q4 2024, and up 732.49% quarter-over-quarter from $7.6 million in Q3 2025.
Analysis
Evotec SE (EVO) Other Operating Expenses (2009 - 2025) Analysis & Trends
Evotec SE has disclosed Other Operating Expenses across 9 years of filings, most recently posting $63.0 million for Q4 2025.
- In Q4 2025, Other Operating Expenses fell 1.01% year-over-year to $63.0 million; the TTM figure through Dec 2025 stood at $96.9 million (up 517.42% YoY), while the FY2025 annual figure was $241.0 million, down 24.21% from the prior year.
- Other Operating Expenses came in at $63.0 million for Q4 2025 at Evotec SE, up from $7.6 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $63.7 million in Q4 2024 to a low of -$70.1 million in Q4 2023.
- Average Other Operating Expenses over 5 years is $1.1 million, with a median of $3.8 million recorded in 2021.
- Year-over-year, Other Operating Expenses tumbled 121278.84% in 2023 and soared 190.76% in 2024.
- Over 5 years, Other Operating Expenses stood at $77539.5 in 2021, then retreated by 25.35% to $57882.7 in 2022, then plunged by 121278.84% to -$70.1 million in 2023, then soared by 190.76% to $63.7 million in 2024, then fell by 1.01% to $63.0 million in 2025.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $63.0 million in Q4 2025, $7.6 million in Q3 2025, and $14.3 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 63.02 Mn |
| Sep 30, 2025 | 7.57 Mn |
| Jun 30, 2025 | 14.30 Mn |
| Mar 31, 2025 | 12.00 Mn |
| Dec 31, 2024 | 63.66 Mn |
| Sep 30, 2024 | 8.01 Mn |
| Jun 30, 2024 | -65.98 Mn |
| Mar 31, 2024 | 10.01 Mn |
| Dec 31, 2023 | -70.14 Mn |
| Jun 30, 2023 | -26.82 Mn |
| Dec 31, 2022 | 57,882.71 |
| Sep 30, 2022 | -19.15 Mn |
| Jun 30, 2022 | 21.22 Mn |
| Mar 31, 2022 | -732.89 |
| Dec 31, 2021 | 77,539.50 |
| Sep 30, 2021 | -20.36 Mn |
| Jun 30, 2021 | 21.77 Mn |
| Mar 31, 2021 | -682.73 |
| Dec 31, 2020 | 80,130.22 |
| Sep 30, 2020 | -21.17 Mn |